MedTrace Logo

Ocular Changes After Ivermectin - (DOLF IVM/Oncho)

NCT03517462 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 231

Last updated 2020-12-31

No results posted yet for this study

Summary

The DOLF Ocular Changes after Ivermectin study will investigate the kinetics of O. volvulus microfilaria (Mf) in the eye following treatment with ivermectin. The primary objective is to determine the proportion of participants with complete Mf clearance from the eye at 3 and 6 months following treatment with ivermectin (IVM).

Conditions

  • Onchocerciasis

Interventions

DRUG

Ivermectin 3Mg Tab

ivermectin tablet

Sponsors & Collaborators

  • Case Western Reserve University

    collaborator OTHER

  • University of Health and Allied Sciences

    collaborator OTHER

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Gary Weil, MD · Washington University School of Medicine

  • Christopher King, MD PhD · Case Western Reserve University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-06
Primary Completion
2019-08-23
Completion
2019-08-23

Countries

  • Ghana

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03517462 on ClinicalTrials.gov